Global and United States Cancer Drugs Market Insights, Forecast to 2026

Publication ID:

QYR11201345

Publication Date:

November 23, 2020

Pages:

140

Publisher:

QYR

Region:

Global [1]

$3,900.00

Description:

Cancer Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Cancer Drugs market is segmented into
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others

Segment by Application, the Cancer Drugs market is segmented into
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others

Regional and Country-level Analysis
The Cancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Cancer Drugs Market Share Analysis
Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Drugs business, the date to enter into the Cancer Drugs market, Cancer Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer
GlaxoSmithKline
Novartis
Sanofi and Pfizer
Amgen
Merck
Bristol-Myers Squibb
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals

Table Of Contents:

1 Study Coverage
1.1 Cancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Cancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Drugs Market Size Growth Rate by Type
1.4.2 Breast Cancer
1.4.3 Blood Cancer
1.4.4 Gastrointestinal Cancer
1.4.5 Prostate Cancer
1.4.6 Skin Cancer
1.4.7 Lung Cancer
1.4.8 Others
1.5 Market by Application
1.5.1 Global Cancer Drugs Market Size Growth Rate by Application
1.5.2 Immunotherapy
1.5.3 Targeted Therapy
1.5.4 Chemotherapy
1.5.5 Hormone Therapy
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Cancer Drugs Revenue 2015-2026
2.1.2 Global Cancer Drugs Sales 2015-2026
2.2 Global Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Cancer Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Cancer Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Cancer Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Cancer Drugs Revenue Forecast by Region (2021-2026)

3 Global Cancer Drugs Competitor Landscape by Players
3.1 Global Top Cancer Drugs Sales by Manufacturers
3.1.1 Global Cancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Cancer Drugs Manufacturers by Revenue
3.2.1 Global Cancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Cancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Drugs Revenue in 2019
3.2.5 Global Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cancer Drugs Price by Manufacturers
3.4 Global Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Cancer Drugs Sales by Type (2015-2020)
4.1.2 Global Cancer Drugs Revenue by Type (2015-2020)
4.1.3 Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Cancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Cancer Drugs Sales by Application (2015-2020)
5.1.2 Global Cancer Drugs Revenue by Application (2015-2020)
5.1.3 Cancer Drugs Price by Application (2015-2020)
5.2 Cancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Drugs Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Cancer Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Cancer Drugs Sales YoY Growth 2015-2026
6.1.2 United States Cancer Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Cancer Drugs Market Share in Global Market 2015-2026
6.2 United States Cancer Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Cancer Drugs Players by Sales (2015-2020)
6.2.2 United States Top Cancer Drugs Players by Revenue (2015-2020)
6.3 United States Cancer Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Cancer Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Cancer Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Cancer Drugs Price by Type (2015-2020)
6.4 United States Cancer Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Cancer Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Cancer Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Cancer Drugs Price Forecast by Type (2021-2026)
6.5 United States Cancer Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Cancer Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Cancer Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Cancer Drugs Price by Application (2015-2020)
6.6 United States Cancer Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Cancer Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Cancer Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Cancer Drugs Price Forecast by Application (2021-2026)

7 North America
7.1 North America Cancer Drugs Market Size YoY Growth 2015-2026
7.2 North America Cancer Drugs Market Facts & Figures by Country
7.2.1 North America Cancer Drugs Sales by Country (2015-2020)
7.2.2 North America Cancer Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Cancer Drugs Market Size YoY Growth 2015-2026
8.2 Europe Cancer Drugs Market Facts & Figures by Country
8.2.1 Europe Cancer Drugs Sales by Country
8.2.2 Europe Cancer Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Cancer Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Cancer Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Cancer Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Cancer Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Cancer Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Cancer Drugs Market Facts & Figures by Country
10.2.1 Latin America Cancer Drugs Sales by Country
10.2.2 Latin America Cancer Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Cancer Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Cancer Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Cancer Drugs Sales by Country
11.2.2 Middle East and Africa Cancer Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Description and Business Overview
12.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Cancer Drugs Products Offered
12.1.5 Bayer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Cancer Drugs Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Cancer Drugs Products Offered
12.3.5 Novartis Recent Development
12.4 Sanofi and Pfizer
12.4.1 Sanofi and Pfizer Corporation Information
12.4.2 Sanofi and Pfizer Description and Business Overview
12.4.3 Sanofi and Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi and Pfizer Cancer Drugs Products Offered
12.4.5 Sanofi and Pfizer Recent Development
12.5 Amgen
12.5.1 Amgen Corporation Information
12.5.2 Amgen Description and Business Overview
12.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amgen Cancer Drugs Products Offered
12.5.5 Amgen Recent Development
12.6 Merck
12.6.1 Merck Corporation Information
12.6.2 Merck Description and Business Overview
12.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck Cancer Drugs Products Offered
12.6.5 Merck Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Corporation Information
12.7.2 Bristol-Myers Squibb Description and Business Overview
12.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bristol-Myers Squibb Cancer Drugs Products Offered
12.7.5 Bristol-Myers Squibb Recent Development
12.8 Celgene Corporation
12.8.1 Celgene Corporation Corporation Information
12.8.2 Celgene Corporation Description and Business Overview
12.8.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Celgene Corporation Cancer Drugs Products Offered
12.8.5 Celgene Corporation Recent Development
12.9 Ariad Pharmaceuticals
12.9.1 Ariad Pharmaceuticals Corporation Information
12.9.2 Ariad Pharmaceuticals Description and Business Overview
12.9.3 Ariad Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ariad Pharmaceuticals Cancer Drugs Products Offered
12.9.5 Ariad Pharmaceuticals Recent Development
12.10 Eli Lilly
12.10.1 Eli Lilly Corporation Information
12.10.2 Eli Lilly Description and Business Overview
12.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Eli Lilly Cancer Drugs Products Offered
12.10.5 Eli Lilly Recent Development
12.11 Bayer
12.11.1 Bayer Corporation Information
12.11.2 Bayer Description and Business Overview
12.11.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bayer Cancer Drugs Products Offered
12.11.5 Bayer Recent Development
12.12 Boehringer Ingelheim
12.12.1 Boehringer Ingelheim Corporation Information
12.12.2 Boehringer Ingelheim Description and Business Overview
12.12.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Boehringer Ingelheim Products Offered
12.12.5 Boehringer Ingelheim Recent Development
12.13 Johnson and Johnson
12.13.1 Johnson and Johnson Corporation Information
12.13.2 Johnson and Johnson Description and Business Overview
12.13.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Johnson and Johnson Products Offered
12.13.5 Johnson and Johnson Recent Development
12.14 Teva Pharmaceuticals
12.14.1 Teva Pharmaceuticals Corporation Information
12.14.2 Teva Pharmaceuticals Description and Business Overview
12.14.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Teva Pharmaceuticals Products Offered
12.14.5 Teva Pharmaceuticals Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Companies Mentioned:

Bayer
GlaxoSmithKline
Novartis
Sanofi and Pfizer
Amgen
Merck
Bristol-Myers Squibb
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.